We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Opko Health
OPK
$1.22B
| $699K | ﹤0.01% |
65,945
+17,250
| +35% | +$172K |
2016 Q2
1 quarter
|
|
|
GUID
2252
DELISTED
Guidance Software, Inc.
GUID
| $698K | ﹤0.01% |
117,100
+14,400
| +14% | +$85.5K |
2016 Q2
1 quarter
|
|
|
FMI
2253
DELISTED
Foundation Medicine, Inc.
FMI
| $696K | ﹤0.01% |
29,801
+22,565
| +312% | +$512K |
2016 Q2
1 quarter
|
|
2254
DELISTED
Dixie Group Inc
DXYN
| $695K | ﹤0.01% |
138,900
+53,100
| +62% | +$219K |
2016 Q2
1 quarter
|
|
2255
Aclaris Therapeutics
ACRS
$564M
| $694K | ﹤0.01% |
27,096
| – | – |
2016 Q2
1 quarter
|
|
2256
German American Bancorp
GABC
$1.92B
| $692K | ﹤0.01% |
26,651
-7,012
| -21% | -$165K |
2016 Q2
1 quarter
|
|
2257
Tandy Leather Factory
TLF
$19.1M
| $689K | ﹤0.01% |
89,941
-74,146
| -45% | -$546K |
2016 Q2
1 quarter
|
|
|
SPA
2258
DELISTED
Sparton
SPA
| $687K | ﹤0.01% |
26,152
-19,125
| -42% | -$439K |
2016 Q2
1 quarter
|
|
|
CNCE
2259
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $686K | ﹤0.01% |
67,881
-20,349
| -23% | -$222K |
2016 Q2
1 quarter
|
|
|
NEWR
2260
DELISTED
New Relic, Inc.
NEWR
| $685K | ﹤0.01% |
17,873
-6,535
| -27% | -$230K |
2016 Q2
1 quarter
|
|
|
GOV
2261
DELISTED
Government Properties Income Trust
GOV
| $683K | ﹤0.01% |
30,212
+13,176
| +77% | +$308K |
2016 Q2
1 quarter
|
|
2262
DELISTED
H&E Equipment Services
HEES
| $680K | ﹤0.01% |
40,580
-13,362
| -25% | -$229K |
2016 Q2
1 quarter
|
|
|
RT
2263
DELISTED
Ruby Tuesday Georgia
RT
| $680K | ﹤0.01% |
272,086
+142,486
| +110% | +$477K |
2016 Q2
1 quarter
|
|
2264
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $680K | ﹤0.01% |
+25,116
| New | +$674K |
2016 Q3
0 quarters
|
|
|
TMX
2265
DELISTED
Terminix Global Holdings, Inc.
TMX
| $678K | ﹤0.01% |
30,044
-71,160
| -70% | -$1.79M |
2016 Q2
1 quarter
|
|
2266
Dave & Buster's
PLAY
$260M
| $676K | ﹤0.01% |
17,252
+8,400
| +95% | +$372K |
2016 Q2
1 quarter
|
|
|
ICPT
2267
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $676K | ﹤0.01% |
4,109
-99
| -2% | -$15.6K |
2016 Q2
1 quarter
|
|
|
CHU
2268
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $676K | ﹤0.01% |
55,467
-109,225
| -66% | -$1.21M |
2016 Q2
1 quarter
|
|
|
SDLP
2269
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $674K | ﹤0.01% |
+19,096
| New | +$807K |
2016 Q3
0 quarters
|
|
2270
Graham Holdings Company
GHC
$5.25B
| $673K | ﹤0.01% |
1,398
-9,910
| -88% | -$4.97M |
2016 Q2
1 quarter
|
|
2271
Plains All American Pipeline
PAA
$18.3B
| $672K | ﹤0.01% |
+21,382
| New | +$611K |
2016 Q3
0 quarters
|
|
2272
SEI Investments
SEIC
$12.5B
| $671K | ﹤0.01% |
14,706
-22,172
| -60% | -$1.04M |
2016 Q2
1 quarter
|
|
|
ESIO
2273
DELISTED
Electro Scientific Industries
ESIO
| $671K | ﹤0.01% |
118,907
-54,574
| -31% | -$319K |
2016 Q2
1 quarter
|
|
2274
Global Indemnity Group
GBLI
$355M
| $669K | ﹤0.01% |
22,523
+20,622
| +1,085% | +$607K |
2016 Q2
1 quarter
|
|
2275
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $666K | ﹤0.01% |
10,705
-5,443
| -34% | -$365K |
2016 Q2
1 quarter
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.